Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins

Journal of Virology

Volumn 74, Issue 5, 2000, Pages 2107-2120

  Schang, Luis M ^a   Rosenberg, Amy ^a   Schaffer, Priscilla A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOHEXIMIDE; ROSCOVITINE; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INHIBITION; GENE EXPRESSION; HERPES SIMPLEX VIRUS; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; CERCOPITHECUS AETHIOPS; CYCLIN-DEPENDENT KINASES; DNA, VIRAL; DOWN-REGULATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, VIRAL; IMMEDIATE-EARLY PROTEINS; MUTATION; PHOSPHONOACETIC ACID; PURINES; RNA, MESSENGER; RNA, VIRAL; SIMPLEXVIRUS; TEMPERATURE; TRANSCRIPTION, GENETIC; VERO CELLS; VIRUS REPLICATION;

EID: 0033975074     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.5.2107-2120.2000     Document Type: Article

References (88)

1. Abraham, R. T., M. Acquarone, A. Andersen, A. Asensi, R. Belle, F. Berger, C. Bergounioux, G. Brunn, C. Buquet-Fagot, D. Fagot, et al. 1995. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biol. Cell 83:105-120.
2. Alessi, F., S. Quarta, M. Savio, F. Riva, L. Rossi, L. Stivala, A. Scovassi, L. Meijer, and E. Prosperi. 1998. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp. Cell Res. 245:8-18.
3. Becker, Y., Y. Asher, Y. Cohen, E. Weinberg-Zahlering, and J. Shlomai. 1997. Phosphonoacetic acid-resistant mutants of herpes simplex virus: effect of phosphonoacetic acid on virus replication and in vitro deoxyribonucleic acid synthesis in isolated nuclei. Antimicrob. Agents Chemother. 11:919-922.
4. Beijersbergen, R. L., L. Carlee, R. M. Kerkhoven, and R. Bernards. 1995. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9:1340-1353.
5. Bohemer, P. E., and I. Lehman. 1997. Herpes simplex virus DNA replication. Annu. Rev. Biochem. 66:347-384.
6. Boulikas, T. 1994. Control of DNA replication by protein phosphorylation. Anticancer Res. 14:2465-2472.
7. Bresnahan, W. A., I. Boldogh, P. Chi, E. A. Thompson, and T. Albrecht. 1997. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231:239-247.
8. Buquet-Fagot, C., F. Lallemand, M. N. Montagne, and J. Mester. 1997 Effects of olomoucine, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines. Anti-Cancer Drugs 8:623-631.
9. Cai, W., and P. A. Schaffer. 1991. A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1. J. Virol. 65:4078-4090.
10. Cardoso, M. C., H. Leonhart, and B. Nadal-Ginard. 1993. Reversal of terminal differentiation and control of DNA replication: cyclin A and cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74:979-992.
11. Chan, A. K., D. W. Litchfield, and J. A. Wright. 1993. Phosphorylation of ribonucleotide reductase R2 protein: in vivo and in vitro evidence of a role for p34cdc2 and CDK2 protein kinases. Biochemistry 32:12835-12840.
12. Chatterjee, A., B. J. Bockus. O. V. Gjørup, and B. S. Schaffhausen. 1997. Phosphorylation sites in polyomavirus large T antigen that regulate its function in viral, hut not cellular DNA synthesis. J. Virol. 71:6472-6478.
13. Cobrinik, D., P. Wnyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 EIA-binding protein. Genes Dev. 7:2392-2404.
14. Coenjaerts, F. E., J. A. W. M. vanOosterhout, and P. C. van der Vliet. 1994. The Oct-1 POU domain stimulates adenovirus DNA replication by a direct interaction between the viral precursor terminal prolein-DNA polymerase complex and the POU domain. J. Virol. 13:5401-5409.
15. Dabrowski, C. E., and P. A. Schaffer. 1991. Herpes simplex virus type 1 origin-specific binding protein: oirS-binding properties and effects of cellular proteins. J. Virol. 65:3140-3150.
16. Daksis, J. I., and C. M. Preston. 1992. Herpes simplex virus immediate early gene expression in the absence of transinduction by Vmw65 varies during the cell cycle. Virology 189:196-202.
17. De Azevedo, W. F., S. Leclerc, L. Meijer, L. Havlicek, M. Strnad, and S. H. Kim. 1997. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur. J. Biochem. 243:518-526.
18. DePamphilis, M. L. 1996. DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
19. Dynlacht, B. 1997. Regulation of transcription by proteins that control the cell cycle. Nature 389:149-152.
20. Dynlacht, B. D., O. Flores, J. A. Lees, and E. Harlow. 1994. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev. 8:1772-1786.
21. Ebert, S., D. Dubramanian, S. Shtrom, I. Chung, D. Parris, and M. Muller. 1994. Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1. J. Virol. 68(2):1010-1020.
22. Girard, F., U. Strausfeld, A. Fernandez, and N. J. Lamb. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67:1169-1179.
23. Glab, N., B. Labidi, L. X. Qin, C. Trehin, C. Bergounioux, and L. Meijer. 1994. Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions. FEBS Lett. 353:207-211.
24. Gold, M. O., J. P. Tassan, E. A. Nigg, A. P. Rice, and C. H. Herrmann. 1996. Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8. Nucleic Acids Res. 24:3771-3777.
25. Goldstein, D. J., and S. K. Weller. 1988. Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant. Virology 166:41-51.
26. Goto, H., S. Motomura, A. C. Wilson, R. N. Freiman, Y. Nakabeppu, K. Fukushima, M. Fujishima, W. Herr, and T. Nishimoto. 1997. A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function. Genes Dev. 11:726-737.
27. Hammersten, O., Y. Xiaodan, and P. Elias. 1996. Inhibition of topoisomerase 11 by ICRF-193 prevents efficient replication of herpes simplex virus type 1. J. Virol. 70:4523-4529.
28. Hassell. J. A., and B. Brinton. 1996. SV40 and polyomavirus DNA replication, p. 639-677. In M. DePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
29. Hay, J., and J. H. Subak-Sharpe. 1976. Mutants of herpes simplex virus types 1 and 2 that are resistant to phosphonoacetic acid induce altered DNA polymerase activity. J. Gen. Virol. 31:145-148.
30. Hay, R. 1996. Adenovirus DNA replication, p. 699-719. In M. DePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
31. Hengst, L., and S. I. Reed. 1998. Inhibitors of the Cip/Kip family. Curr. Top. Microbiol. Immunol. 227:25-41.
32. Henley, D. C., and J. P. Weir. 1991. The relative stability of selected herpes simplex virus type 1 mRNAs. Virus Res. 20:121-132.
33. Hilton, M. J., D. Mounghane, T. McLean, N. V. Contractor, J. O'Neil, K. Carpenter, and S. L. Bachenheimer. 1995. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor. Virology 213: 624-638.
34. Hofmann, F., and D. M. Livingston. 1996. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit. Genes Dev. 10:851-861.
35. Honess, R. W., and B. Roizman. 1974. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:8-19.
36. Honess, R. W., and D. H. Watson. 1977. Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J. Virol. 21:584-600.
37. Hossain, A., T. Holt, J. Ciacci-Zanella, and C. Jones. 1997. Analysis of cyclin-dependent kinase activity after herpes simplex virus type 2 infection. J. Gen. Virol. 78:3341-3348.
38. Iseki, H., T. C. Ko, X. Y. Xue, A. Seapan, M. R. Hellmich, and C. M. Townsend, Jr. 1997. Cyclin-dependent kinase inhihitors block proliferation of human gastric cancer cells. Surgery 122:187-194.
39. Jackman, M. R., and J. N. Pines. 1997. Cyclins and the G2/M transition. Cancer Surv. 20:47-73.
40. Jiang, W., N. J. Wells, and T. Hunter. 1999. Multistep regulation of DNA replication by Cdk phosphorylation of HsCdc6. Proc. Nat. Acad. Sci. USA 96:6193-6198.
41. Jofre, J. T., R. J. Courtney, and P. A. Schaffer 1981. A dominant lethal temperature-sensitive mutant of herpes simplex virus type 1. Virology 111: 173-190.
42. Jofre, J. T., P. A. Schaffer, and D. S. Parris. 1977. Genetics of resistance to phosphonoacetic acid in strain KOS of herpes simplex virus type 1. J. Virol. 23:833-836.
43. Jordan, R., and P. A. Schaffer. 1997. Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. J. Virol. 71:6850-6862.
44. Jordan, R., L. M. Schang, and P. A. Schaffer. 1999. Transactivation of HSV-1 IE gene expression by virion-associated factors is blocked by an inhibitor of cyclin-dependent protein kinases. J. Virol. 73:843-847.
45. Kawaguchi, Y., C. Van Sant, and B. Roizman. 1997. Herpes simplex virus 1 alpha regulatory protein ICPO interacts with and stabilizes the cell cycle regulator cyclin D3. J. Virol. 71:7328-7336.
46. Kim, C. G., E. Y. Shim, J. E. Lee, Y. K. Jang, C. G. Lee, and S. D. Park. 1994. Allosteric interaction of a herpes simplex viral thymidine kinase with host DNA polymerase alpha in mouse LP1-1 cells. Biochem. Mol. Biol. Int. 32:651-657.
47. Kitagawa, M., H. Higashi. I. Suzuki-Takahashi, K. Segawa, S. K. Hanks, Y. Taya, S. Nishimura, and A. Okuyama. 1995. Phosphorylation of E2F-1 by cyclin A-cdk2. Oncogene 10:229-236.
48. Krude, T., M. Jackman, J. Pines, and R. A. Laskey. 1997. Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell 88:109-119.
49. Leclerc, V., J. P. Tassan, P. H. O'Farrell, E. A. Nigg, and P. Leopold. 1996. Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II. Mol. Biol. Cell 7:505-513.
50. Lee, S.-K., Q. Dong, and I. Lehman. 1995. Interaction of herpes simplex virus 1 origin-binding protein with DNA polymerase α. Proc. Natl. Acad. Sci. USA 92:7882-7886.
51. Li, H., S. Bhattacharye, and C. Prives. 1997. Cyclin-dependent kinase regulation of the replication functions of polyomavirus large T antigen. J. Virol. 71:6479-6485.
52. cdk2 complexes binding to a human thymidine kinase promoter element important for G1-S phase transcriptional regulation Proc. Nat. Acad. Sci. USA 90:3554-3558.
53. Mao, J. G.-H., E. E. Robinshaw, and L. R. Overby. 1975. Inhibition of DNA polymerase from herpes simplex virus-infected Wi-38 cells by phosphonoacetic acid. J. Virol. 15:1281-1283.
54. Martín-Castellanos, C., and S. Moreno. 1997. Recent advances on cyclins. CDKs and CDK inhibitors. Trends Cell Biol. 7:95-98.
55. McGeoch, D., B. Barnett, and C. McLean. 1993. Emerging functions of alphaherpesvirus genes. Semin. Virol. 4:125-134.
56. Meijer, L., A. Borgne, O. Mulner, J. P. Chong, J. J. Blow, N. lnagaki, M. lnagaki, J. G. Delcros, and J. P. Moulinoux. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:527-536.
57. Nguyen-Huynh, A. T., and P. A. Schaffer. 1998. Cellular transcription factors enhance herpes simplex virus type 1 oriS-dependent DNA replication. J. Virol. 72:3635-3645.
58. Nichol, P. F., J. Y. Chang, E. M. Johnson, Jr., and P. D. Olivo. 1996. Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways. J. Virol. 70:5476-5486.
59. Olivo, P. D., N. J. Nelson, and M. D. Challberg. 1989. herpes simplex virus type 1 gene products required for DNA replication: identification and over-expression. J. Virol. 63:196-204.
60. Oroskar, A. A., and S. G. Read. 1989. Control of mRNA stability by the virion host shutoff function of herpes simplex virus. J. Virol. 63:1897-1906.
61. Overby, L., E. Robishaw, J. Schleicher, A. Reuter, N. Shipkowitz, and J.-H. Mao. 1974. Inhibition of herpes simplex virus replication by phosphonoacetic acid. Antimicrob. Agents Chemother. 6:360-365.
62. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961-971.
63. Parris, D. S., R. J. Courtney, and P. A. Schaffer. 1978. Temperature-sensitive mutants of herpes simplex virus type 1 defective in transcriptional and post-transcriptional functions required for viral DNA synthesis. Virology 90:177-186.
64. Purves, F. C., and B. Roizman. 1992. The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein alpha 22, Proc. Natl. Acad. Sci. USA 89:7310-7314.
65. Reed, S. I. 1996. G1/S regulatory mechanisms from yeast to man. Prog. Cell Cycle Res. 2:15-27.
66. Rickert, P., W. Seghezzi, F. Shanahan, H. Cho, and E. Lees. 1996. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene 12:2631-2640.
67. Rieber, M., and M. S. Rieber. 1994. Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 melanoma terminal differentiation. Cell Growth Differ. 5:1339-1346.
68. Rosenberg, A. R., F. Zindy, F. Le Deist, H. Mouly, P. Metezeau, C. Brechot, and E. Lamas. 1995. Overexpression of human cyclin A advances entry into S phase. Oncogene 10:1501-1509.
69. Schaffer, P. A., G. M. Aron, N. Biswal, and M. Benyesh-Melnick. 1973. Temperature-sensitive mutants of herpes simplex virus type 1: isolation, complementation and partial characterization. Virology 52:57-71.
70. Schang, L. M., J. Phillips, and P. A. Schaffer. 1998. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J. Virol. 72:5626-5637.
71. Schang, L. M., A. Rosenberg, and P. A. Schaffer. 1999. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases. J. Virol. 73:2161-2172.
72. Schulze-Gahmen, U., J. Brandsen, H. D. Jones, D. O. Morgan, L. Meijer, J. Vesely, and S. H. Kim. 1995. Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine. Proteins 22:378-391.
73. Serizawa, H., T. P. Makela, J. W. Conaway, R. C. Conaway, R. A. Weinberg, and R. A. Young. 1995. Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature 374:280-282.
74. Shiekhattar, R., F. Mermelstein, R. P. Fisher, K. Drapkin, B. Dynlacht, H. C. Wessling, D. O. Morgan, and D. Reinberg. 1995. Cdk-activating kinase complex is a component of human transcription factor. Nature 374:283-287.
75. Skaliter, R., and I. Lehman. 1994. Rolling circle DNA replication in vitro by a complex of herpes simplex virus type 1-encoded enzymes. Proc. Natl. Acad. Sci. USA 91:10665-10669.
76. Smith, E. J., and J. R. Nevins. 1995. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2. Mol. Cell. Biol. 15:338-344.
77. Stenlund, A. 1996. Papillomavirus DNA replication, p. 679-697. In M. De-Pamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
78. Umene, K., and T. Nishimoto. 1996. Inhibition of generation of authentic genomic termini of herpes simplex virus type 1 DNA in temperature-sensitive mutant BHK-21 cells with a mutated CCG1/TAF(II)250 gene. J. Virol. 70:9008-9012.
79. van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054.
80. Van Sant, C., Y. Kawaguchi, and B. Roizman. 1999. A single amino acid substitution in the cyclin D binding domain of the infected cell protein no. 0 abrogates the neuroinvasiveness of herpes simplex virus without affecting its ability to replicate. Proc. Natl. Acad. Sci. USA 96:8184-8189.
81. Vesely, J., L. Havlicek, M. Strnad, J. J. Blow, A. Donella-Deana. L. Pinna, D. S. Letham, J. Kato, L. Detivaud, S. Leclerc, and L. Meijer. 1994. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224:771-786.
82. Weisshart, K., and E. Fanning. 1996. Roles of phosphorylation in DNA replication, p. 295-329. In M. DePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory press, Cold Spring Harbor, N.Y.
83. Wilcock, D., and D. P. Lane. 1991. Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. Nature 349:429-431.
84. Wilson, A. C., R. N. Freiman, H. Goto, T. Nishimoto, and W. Herr. 1997. VP16 targets an amino-terminal domain of HCF involved in cell cycle progression. Mol. Cell. Biol. 17:6139-6146.
85. Xu, M., K. A. Sheppard, C. Y. Peng, A. S. Yee, and H. Piwnica-Worms. 1994. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14:8420-8431.
86. Yanagi, K., A. Talavera, T. Nishimoto, and M. G. Rush. 1978. Inhibition of herpes simplex virus type 1 replication in temperature-sensitive cell cycle mutants. J. Virol. 25:42-50.
87. Ye, M., K. M. Duus, J. Peng, D. H. Price, and C. Grose. 1999. Varicellazoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase. J. Virol. 73:1320-1330.
88. Zindy, F., E. Lamas, X. Chenivesse, J. Sobczak, J. Wang, D. Fesquet, B. Henglein, and C. Brechot. 1992. Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun. 182:1144-1154.